Resultados da pesquisa - (((((("d_ opens") OR ("o opens"))) OR ("esmo open"))) OR ((("so open") OR ("caso open"))))

Pesquisas alternativas:
"esmo open" » "esto open" (Expandir a Pesquisa), "eso open" (Expandir a Pesquisa), "ecmo open" (Expandir a Pesquisa)
"caso open" » "case open" (Expandir a Pesquisa)

1

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

Por Zielinski, Christoph C, Pinto, Carmine
Publicado no ESMO Open (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

ESMO Open—Cancer Horizons and the future of oncology

ESMO Open—Cancer Horizons and the future of oncology

Por Zielinski, Christoph C
Publicado no ESMO Open (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

CSCO joins ESMO Open—Cancer Horizons

CSCO joins ESMO Open—Cancer Horizons

Por Zielinski, Christoph C, Wu, Yi-Long
Publicado no ESMO Open (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

ESMO Open: news in breast cancer 2019

ESMO Open: news in breast cancer 2019

Por Lambertini, Matteo
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

Por Ohe, Yuichiro, Zielinski, Christoph
Publicado no ESMO Open (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

ESMO Open special series on new emerging targets in cancer immunotherapy

ESMO Open special series on new emerging targets in cancer immunotherapy

Por Lambertini, Matteo
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

Por Morgan, Gilberto, Preusser, Matthias, Zielinski, Christoph
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

One year of ESMO Open: Cancer Horizons—where are we going from here?

One year of ESMO Open: Cancer Horizons—where are we going from here?

Por Zielinski, Christoph
Publicado no ESMO Open (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Plasmodesmata. A Not So Open-and-Shut Case

Plasmodesmata. A Not So Open-and-Shut Case

Por Oparka, K. J., Roberts, A. G.
Publicado em 2001

Obter o texto integral
Obter o texto integral

Artigo

10

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Por Preusser, Matthias
Publicado no ESMO Open (2019)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion

Por Burke, Patrick W, Hoelzer, Dieter, Park, Jae H, Schmiegelow, Kjeld, Douer, Dan
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

Por Banerjee, Susana, Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N, Oaknin, Ana, Ray-Coquard, Isabelle
Publicado no ESMO Open (2020)

“... with bevacizumab in homologous recombination deficiency-positive-associated advanced ovarian cancer. An ESMO Open...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

Por Awada, Ahmad, Gligorov, Joseph, Jerusalem, Guy, Preusser, Matthias, Singer, Christian, Zielinski, Christoph
Publicado no ESMO Open (2019)

“...In December 2017, ESMO Open—Cancer Horizons convened a round-table discussion on the background...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

EDUCAÇÃO A DISTÂNCIA: O CASO OPEN UNIVERSITY

EDUCAÇÃO A DISTÂNCIA: O CASO OPEN UNIVERSITY

Por Marta de Campos Maia, Fernando De Souza Meirelles
Publicado no RAE-eletrônica (2002)

Obter o texto integral

Artigo

15

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

Por Lambertini, Matteo, Preusser, Matthias, Zielinski, Christoph C
Publicado no ESMO Open (2019)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

Por Lamarca, A., Foster, L., Satyadas, T., Siriwardena, A., Valle, J.W.
Publicado no ESMO Open (2021)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

En soutien aux personnels d’OpenEdition

En soutien aux personnels d’OpenEdition

Publicado em 2020-02-01

Obter o texto integral

Artigo

18

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Por Peleg Hasson, S., Brezis, M.R., Shachar, E., Shachar, S.S., Wolf, I., Sonnenblick, A.
Publicado no ESMO Open (2021)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

Study of induced current of 3D-open-shell-electrode detector

Study of induced current of 3D-open-shell-electrode detector

Por Qian Nie, Chuan Liao, Manwen Liu, Zheng Li
Publicado em 2020-03-01

“... Laboratory, a novel three-dimensional (3D) detector, the 3D-Open-Shell-Electrode Detector (3DOSED...”
Obter o texto integral

Artigo

20

Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]

Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]

Por Shi, L., Xu, C., Ma, Y., Ou, Q., Wu, X., Lu, S., Shao, Y., Guo, R., Kong, J.
Publicado no ESMO Open (2021)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[65]